Phase II study of cisplatin, epirubicin, and continuous-infusion 5-fluorouracil for advanced biliary tract cancer

被引:23
作者
Morizane, C [1 ]
Okada, S [1 ]
Okusaka, T [1 ]
Ueno, H [1 ]
Saisho, T [1 ]
机构
[1] Natl Canc Ctr, Div Hepatobiliary & Pancreat Oncol, Chuo Ku, Tokyo 1040045, Japan
关键词
D O I
10.1159/000070310
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:475 / 476
页数:2
相关论文
共 2 条
[1]   EPIRUBICIN, CISPLATIN AND INFUSIONAL 5-FLUOROURACIL (5-FU) (ECF) IN HEPATOBILIARY TUMORS [J].
ELLIS, PA ;
NORMAN, A ;
HILL, A ;
OBRIEN, MER ;
NICHOLSON, M ;
HICKISH, T ;
CUNNINGHAM, D .
EUROPEAN JOURNAL OF CANCER, 1995, 31A (10) :1594-1598
[2]   A PHASE-II STUDY IN ADVANCED GASTROESOPHAGEAL CANCER USING EPIRUBICIN AND CISPLATIN IN COMBINATION WITH CONTINUOUS-INFUSION 5-FLUOROURACIL (ECF) [J].
FINDLAY, M ;
CUNNINGHAM, D ;
NORMAN, A ;
MANSI, J ;
NICOLSON, M ;
HICKISH, T ;
NICOLSON, V ;
NASH, A ;
SACKS, N ;
FORD, H ;
CARTER, R ;
HILL, A .
ANNALS OF ONCOLOGY, 1994, 5 (07) :609-616